ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

The Level of Plasm Donor-Derived Cell-Free DNA in Kidney Transplant Patients with Severe Pneumonia

L. Liu1, H. Liu2, F. Liu2, L. Shu2, L. Peng1

1Xiangyang Hospital No. 2 of Central South University, Changsha, China, 2AlloDx, Shanghai
Suzhou, China

Meeting: 2020 American Transplant Congress

Abstract number: B-185

Keywords: Infection, Kidney

Session Information

Session Name: Poster Session B: All Infections (Excluding Kidney & Viral Hepatitis)

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Pulmonary infection is one of the common complications after kidney transplantation. Donor-derived cell-free DNA (ddcfDNA) is a new biomarker to diagnose allograft injury. Currently, it is unclear how ddcfDNA levels change in kidney transplant patients with severe pneumonia.

*Methods: Through pathogen culture, immunofluorescence assay and qPCR assay, 13 kidney transplant patients were diagnosed with pneumonia (IDSA/ATS criteria) have been recruited, and paired plasm samples were collected on the 1st day of diagnosis (infection subgroup) and on the 7th day after treatment (resolving subgroup). Meanwhile, 42 patients at stable phase were selected as the stable group. Total cfDNA was extract from plasma and quantification by Qubit 3.0, ddcfDNA(%) quantification through target region capture sequencing and calculated by maximum likehood estimation (MLE). Set absolute quantification of ddcfDNA as copies per mL plasma (cp/mL) is calculated by multiplying the total concentration of cfDNA(cp/mL) by the ddcfDNA fraction (%).

*Results: 22 pathogens were detected, including 16 bacterial (i.e. PAE, ABA, KPN), 4 viral (i.e. CMV, EB), 2 fungal (i.e. Aspergillus, PCP). And detect negative on the 7th day of treatment.The mean of total cfDNA concentration in infection, resolving and stable subgroup was 222±78.9 ng/mL, 77±34.5ng/mL, 60±24.4ng/mL, respectively. Significant differences between infection group and resolving subgroup(p=0.024)/stable subgroup(p=0.021) was found, but no significant difference between resolving subgroup and stable subgroup (p>0.05).For fraction of ddcfDNA (%) analysis, the mean ddcfDNA(%) of three subgroups was 0.58%±0.12%, 0.58%±0.16%, 0.54%±0.08%, respectively. No significant differences exists among three subgroups (p>0.05). For absolute ddcfDNA quantification, the mean ddcfDNA(cp/mL) in aforementioned subgroups was 94.6±29.26cp/mL, 56.41±13.43cp/mL, 49.81±10.09cp/mL, respectively. Significant differences in the distribution of ddcfDNA were found between infection subgroup and resolving subgroup (p=0.044)/stable subgroup (p=0.016), but no significant difference between the resolving and stable subgroup (p=0.423). (Figure 1).

 border=

*Conclusions: Severe pneumonia can cause kidney injury, and increase absolute amount of ddcfDNA in plasma, but no change to fraction of ddcfDNA. The fraction of ddcfDNA could be diluted by activated lymphocytes caused by infection, suggesting that using ddcfDNA fraction to detect rejection, severe pneumonia does not affect the detection specificity of ddcfDNA.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Liu L, Liu H, Liu F, Shu L, Peng L. The Level of Plasm Donor-Derived Cell-Free DNA in Kidney Transplant Patients with Severe Pneumonia [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/the-level-of-plasm-donor-derived-cell-free-dna-in-kidney-transplant-patients-with-severe-pneumonia/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences